Efficacy of treatment with brodalumab after treatment failure of previous interleukin 17A inhibitors in patients with psoriasis

被引：0
|
作者：
Loft, Nikolai [1 ,2 ]
Bregnhoj, Anne [3 ]
Fage, Simon [3 ]
Nielsen, Claus Henrik [4 ]
Enevold, Christian [4 ]
Zachariae, Claus [1 ,2 ,3 ]
Iversen, Lars [3 ]
Skov, Lone [1 ,2 ]
机构：
[1] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Dermatol & Allergy, Hellerup, Denmark
[2] Herlev & Gentofte Hosp, Copenhagen Res Grp Inflammatory Skin, Hellerup, Denmark
[3] Aarhus Univ Hosp, Dept Dermatol, Aarhus, Denmark
[4] Copenhagen Univ Hosp, Rigshosp, Inst Inflammat Res, Ctr Rheumatol & Spine Dis, Copenhagen, Denmark
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
26580
引用
收藏
页码：AB107 / AB107
页数：1
相关论文
共 50 条
  • [1] Effectiveness of brodalumab after previous treatment failure of interleukin-17A inhibitors in patients with psoriasis
    Loft, Nikolai
    Bregnhoj, Anne
    Fage, Simon
    Nielsen, Claus Henrik
    Enevold, Christian
    Zachariae, Claus
    Iversen, Lars
    Skov, Lone
    DERMATOLOGIC THERAPY, 2021, 34 (06)
  • [2] Brodalumab in the treatment of moderate to severe psoriasis in patients when previous anti-interleukin 17A therapies have failed
    Kimmel, Grace
    Chima, Margot
    Kim, Hee Jin
    Bares, Jennifer
    Yao, Christopher J.
    Singer, Giselle
    Kim, Soo Jung
    Bagel, Jerry
    Lebwohl, Mark
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (03) : 857 - 859
  • [3] Shaping Treatment Expectation to Optimize Efficacy of Interleukin 17A Antagonist Secukinumab in Psoriasis Patients
    Hoelsken, Stefanie
    Krefting, Frederik
    Muehlhaus, Senta
    Bese, Daniela
    Schedlowski, Manfred
    Sondermann, Wiebke
    PSORIASIS-TARGETS AND THERAPY, 2025, 15 : 9 - 22
  • [4] Brodalumab success in patients with moderate-to-severe psoriasis who failed previous interleukin-17A inhibitors
    Yeung, Jensen
    Vender, Ron
    Turchin, Irina
    Shukla, Rahul
    Maari, Catherine
    Hong, Chih-ho
    Barakat, Maxime
    Lansang, Perla
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (04) : 1169 - 1171
  • [5] Brodalumab treatment in psoriasis patients with severe renal failure
    Ribero, Simone
    Conti, Valeria
    Gambardella, Alessio
    De Rosa, Alina B.
    Dapavo, Paolo
    Argenziano, Giuseppe
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2021, 156 (03) : 406 - 408
  • [6] Safety and efficacy of brodalumab for psoriasis after 120 weeks of treatment
    Papp, Kim
    Leonardi, Craig
    Menter, Alan
    Thompson, Elizabeth H. Z.
    Milmont, Cassandra E.
    Kricorian, Greg
    Nirula, Ajay
    Klekotka, Paul
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 71 (06) : 1183 - U399
  • [7] Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review of Post Hoc Analyses
    Lebwohl, Mark G.
    Armstrong, April W.
    Alexis, Andrew F.
    Lain, Edward L.
    Jacobson, Abby A.
    DERMATOLOGY AND THERAPY, 2024, 14 (10) : 2709 - 2726
  • [8] Brodalumab/elasomeranExacerbation of psoriasis vulgaris and treatment failure
    Reactions Weekly, 2024, 1992 (1) : 54 - 54
  • [9] Brodalumab in the treatment of moderate-to-severe psoriasis in patients who have previously failed treatment with anti-interleukin-17A therapies
    Kimmel, Grace
    Chima, Margot
    Kim, Hee Jin
    Yao, Christopher
    Singer, Giselle
    Lebwohl, Mark
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB177 - AB177
  • [10] Interleukin-17 Inhibitors work best in the Treatment of Psoriasis
    Di Lellis, Maddalena Angela
    AKTUELLE DERMATOLOGIE, 2020, 46 (04)
12345